Also in this playlist...
This transcript is automatically generated
They say as a smashing breakthrough.
Vaccine actually that's designed to fight one of the most common and aggressive forms of brain cancer.
-- -- studies show that the vaccine could potentially improve survival.
By extending the lives of patients doctor Siegel these really city big news if it's if it's the case.
You know it's very promising and everyone out there is word about this because everyone's worried they're gonna get a brain tumor even -- -- about 5000 cases per year of this it's really severe type colloquial blessed moment now.
The reality is that you can't really cure this I mean you can't really remove it and curious because actually Eric -- you take it out it almost always comes back.
And the five year survival rate for this is under 5% it's terrible so what they did in this study -- us.
They took the tumor as they were removing it and they used it to cause the body's immune system to -- -- to -- antibodies to a two.
Targeted for destruction and then they put that in a body back -- basically.
And then they found that the patient live longer.
The patient with recurrent brain tumor lived about -- -- -- 67 months now that's.
Very preliminary and in my opinion this is just the beginning I mean the the study's author doctor parts of from UCSF -- to me that.
-- cancer would be a chronic disease coming up in the future you know maybe this is since it's a non -- vaccine maybe this is the future of cancer treatment.
It's very preliminary and the results are at this point.
Very modest but for people out there look.
Brain tumors you're not getting them every day if you have a severe headache if you're having seizures if you're having behavioral changes things we saw with Senator Ted Kennedy.
Then you might start to look into this but I get this question every day.
And this is a very deadly disease so we like to see this kind of cure potentially on the.
Or -- is my this is such an aggressive form we've had it in our family.
And -- and you certainly hope that it can be.
You know it's very unfortunate because it's one of the most common brain tumors is also very aggressive and has stuck to -- -- The prognosis is -- surgery is the main treatment for this and and when you remove.
And that's the number 98 for some of the tumor.
Then the rest you can hit them and radiation and chemotherapy so.
I think there hasn't been a really good news for the last three decades for this type of tumor.
This is certainly it's a clinical trial it's a face to either exactly as doctor -- mention what -- works is that by removing the tumor itself.
You purified you get the cancer cells out -- do you take kept rotating you give it back to the patient.
This is -- personalized medicine as it's going to get wide.
Because when that -- thing comes back in.
The immune system is gonna look at this as a foreign thing wait -- second -- gonna get -- -- what we call.
Key kid ourselves the soldiers -- general of the army is gonna go after this god.
And what it does it cures or near the Kansas does that are remaining I think it's fascinating I think this is it is still at the very -- -- phase.
There's only 41 patients in this study but I think it's a great news for this type of cancer because we haven't had for years.
And while furthering it researches is -- -- -- necessary.
I think for people who had this kind of brain -- there is hope.
Few percentages are going for a long time you know I do with cancer day in and day out and I don't think it did the power of the brain is very important.
Get it to some of his clinical studies there's about it centers across US mainly McNamee and his San Francisco.
And and and hope you know we'll have better result in the future it sounds --
Filter by section